June 29, 2012
CAMBRIDGE, Mass. — Companies are going public in Massachusetts. In fact, the first IPOs to list on the Nasdaq since Facebook are Bay State companies Tesaro, a cancer drug developer, and Exa, a maker of design software for vehicles. Both had modest debuts this week. But meanwhile, another recently minted public company is trying to create the future of retail. Burlington-based Demandware makes software designed to help brands and retailers reach more shoppers online. The company, which is valued at over $700 million, is going after fashion and luxury brands — avoiding low-end commodities, where Amazon is dominant.
In other innovation news …
A new report shows that in the first quarter of 2012, venture investing by corporations hit its lowest dollar sum in over a year. Massachusetts saw the majority of corporate VC money go to its health care startups.
Our deal of the week goes to Cambridge-based Seaside Therapeutics. The company has a new partnership with Swiss pharmaceutical giant Roche to develop drugs for autism spectrum disorders.
And fellow Cambridge startup Nara Logics has launched a website that’s designed to work like the human brain. It adapts to consumers’ preferences to help them discover new restaurants. Sounds like it could help us all branch out a bit this weekend.
The weekly roundup of business, technology and life science news from our partners at Xconomy.com airs every Friday on 89.7 Boston Public Radio.
Comment on This Article
Subscribe to WGBH News Emails